Stay updated on Pyrotinib Combo in HR+/HER2- Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib Combo in HR+/HER2- Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib Combo in HR+/HER2- Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page’s footer revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a general platform release rather than modifications to the clinical trial record content.
    Difference
    0.1%
    Check dated 2026-04-24T05:54:44.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 to the record history and removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:24:56.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    46 days ago
    Change Detected
    Summary
    Revision v3.5.0 was added and revision v3.4.3 was deleted from the Study Record Versions.
    Difference
    0.1%
    Check dated 2026-03-19T04:57:24.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Added a new history entry Revision: v3.4.3 and removed Revision: v3.4.2 from the Study Record history.
    Difference
    0.1%
    Check dated 2026-03-12T02:55:06.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the record history. The previous government funding notice (Revision: v3.4.1) was removed.
    Difference
    0.9%
    Check dated 2026-02-11T10:19:59.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    A general site-wide notice about government funding and NIH Clinical Center status was added. The page revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.9%
    Check dated 2026-02-04T06:41:21.000Z thumbnail image

Stay in the know with updates to Pyrotinib Combo in HR+/HER2- Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib Combo in HR+/HER2- Clinical Trial page.